Boston Scientific Corp
NYSE:BSX

Watchlist Manager
Boston Scientific Corp Logo
Boston Scientific Corp
NYSE:BSX
Watchlist
Price: 104.5 USD -0.01% Market Closed
Market Cap: 154.6B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+15%
Revenue
Forecast
+13%
Operating Income
Forecast
+30%
Net Income
Forecast
+44%

Wall Street
Price Targets

BSX Price Targets Summary
Boston Scientific Corp

Wall Street analysts forecast BSX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BSX is 120.09 USD with a low forecast of 84.95 USD and a high forecast of 136.5 USD.

BSX Lowest Forecast
Wall Street Target
84.95 USD
19% Downside
BSX Average Forecast
Wall Street Target
120.09 USD
15% Upside
BSX Highest Forecast
Wall Street Target
136.5 USD
31% Upside
Lowest
Price Target
84.95 USD
19% Downside
Average
Price Target
120.09 USD
15% Upside
Highest
Price Target
136.5 USD
31% Upside
Boston Scientific Corp Competitors:
Price Targets
M
305090
Micro Digital Co Ltd
131% Upside
6869
Sysmex Corp
40% Upside
MDT
Medtronic PLC
19% Upside
BDX
Becton Dickinson and Co
29% Upside
M
305090
Micro Digital Co Ltd
131% Upside
6869
Sysmex Corp
40% Upside
MDT
Medtronic PLC
19% Upside
BDX
Becton Dickinson and Co
29% Upside
AORT
Artivion Inc
11% Upside
CLPT
Clearpoint Neuro Inc
133% Upside

Revenue
Forecast

Revenue Estimate
Boston Scientific Corp

For the last 8 years the compound annual growth rate for Boston Scientific Corp's revenue is 9%. The projected CAGR for the next 3 years is 13%.

9%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Boston Scientific Corp

For the last 8 years the compound annual growth rate for Boston Scientific Corp's operating income is 11%. The projected CAGR for the next 3 years is 30%.

11%
Past Growth
30%
Estimated Growth
Estimates Accuracy
-33%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Boston Scientific Corp

For the last 8 years the compound annual growth rate for Boston Scientific Corp's net income is 23%. The projected CAGR for the next 3 years is 44%.

23%
Past Growth
44%
Estimated Growth
Estimates Accuracy
-54%
Average Miss
What are analyst estimates?

See Also

Summary
BSX intrinsic value, competitors valuation, and company profile.
DCF Valuation
BSX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BSX stock valuation using valuation multiples.
Wall Street Estimates
BSX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BSX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BSX's stock price target?
Price Target
120.09 USD

According to Wall Street analysts, the average 1-year price target for BSX is 120.09 USD with a low forecast of 84.95 USD and a high forecast of 136.5 USD.

What is Boston Scientific Corp's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Boston Scientific Corp's revenue is 9%. The projected CAGR for the next 3 years is 13%.

What is Boston Scientific Corp's Operating Income forecast?
Projected CAGR
30%

For the last 8 years the compound annual growth rate for Boston Scientific Corp's operating income is 11%. The projected CAGR for the next 3 years is 30%.

What is Boston Scientific Corp's Net Income forecast?
Projected CAGR
44%

For the last 8 years the compound annual growth rate for Boston Scientific Corp's net income is 23%. The projected CAGR for the next 3 years is 44%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 258,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.